Cytocom ticker
WebApr 10, 2024 · The company is developing therapies designed to directly elicit within patients a response of antigen-specific killer T-cells and antibodies, thereby activating … WebCytocom is a biopharmaceutical company focused on analogs that treat multiple diseases. Fort Collins, Colorado, United States 11-50 Post-IPO Equity Public www.cytocom.com …
Cytocom ticker
Did you know?
WebJun 17, 2024 · The Registration Statement includes a definitive proxy statement and a prospectus. Notice of the Special Meeting and the definitive proxy statement/prospectus was mailed to stockholders of the Company as of June 9, 2024.. Subsequent to the closing of the merger, the new combined company will be named "Cytocom Inc.", and its common … WebAug 31, 2024 · Contacts: Cytocom, Inc. Nichol Ochsner Senior V.P. Investor Relations and Corporate Communications (732) 754-2545 [email protected] Tiberend …
WebOct 20, 2024 · Cytocom and Cleveland Biolabs expect the transaction to close during the first quarter of 2024. Conference Call. Cytocom will host a conference call and live audio webcast at 8:00 a.m. EDT on October 28 th to discuss the merger and provide a strategic vision for the combined company. To access the conference call supported with slides, … WebAug 31, 2024 · FORT COLLINS — Cytocom Inc. (Nasdaq: CBLI) changed its name to Statera BioPharma Inc. and gets a new ticker symbol, effective Wednesday, Sept. 1, a …
WebHow can I view documents Cytocom has filed with the Securities & Exchange commission (SEC) including Forms 10-K and 10-Q? Cytocom’s SEC Filings can be found on … WebMay 26, 2024 · FORT COLLINS — Another special purpose acquisition company is preparing to launch along the northern Front Range with Cytocom Inc. CEO Michael Handley at the helm. Sparta Healthcare Acquisition Corp. is seeking to raise up to $115 million in a bid to join the Nasdaq Capital Market under the ticker “SPTAU”, according to …
WebAug 5, 2024 · FORT COLLINS, Colo., Aug. 5, 2024 /PRNewswire/ -- Cytocom Inc. (NASDAQ: CBLI ), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and ...
WebOct 20, 2024 · The Boards of Directors of both companies have approved the combination.For Immune Therapeutics, Inc. (Ticker: IMUN) and it’s shareholders who hold a considerable stake in Cytocom this means ... incomber synWebCytocom has raised a total of $94.3M in funding over 3 rounds. Their latest funding was raised on Jul 29, 2024 from a Post-IPO Equity round. Cytocom is registered under the … incense for churchWebSep 7, 2024 · On September 1, 2024, Cytocom officially became listed as Statera BioPharma, Inc. (NASDAQ: STAB), as it updated its ticker symbol from CLBI to STAB within the Nasdaq markets. This change in name ... incomber usitoWebRestoring Immune Health Statera Biopharma's foundation is based on restoring immune health through the leveraging of complex pleiotropic beneficial effects. Read The Story STAT-200: noroxymorphone analogs STAT-200 compositions modulate the OGF-OGFr axis (homeostatic regulator of cell proliferation), as well as Toll-like receptors (TLRs) and … incomberiezWebAug 16, 2024 · The Company’s common stock began trading on Nasdaq under the post-merger name, Cytocom, Inc., with the current ticker symbol "CBLI" at the opening bell on July 28, 2024. Secured commitments for capital with agreements providing for $90 million in debt and equity financing to continue advancing the Company’s product pipeline. incombere aWebCYTO-200 Noroxymorphone Platform. CYTO-200 program therapies, are noroxymorphone analogs developed by discovering the anti-angiogenic and anti-inflammatory properties of naltrexone, yielding a new way of fighting … incomber utilisationWebJul 28, 2024 · Shares of the new Cytocom's common stock will begin trading on Nasdaq under the ticker symbol "CBLI," at the opening bell on Wednesday, July 28, 2024. As previously reported, the newly combined... incense games